ZA855124B - Phenol-naphthyridines,process for preparing them,drugs containing them,particularly anti-ulcer drugs - Google Patents
Phenol-naphthyridines,process for preparing them,drugs containing them,particularly anti-ulcer drugsInfo
- Publication number
- ZA855124B ZA855124B ZA855124A ZA855124A ZA855124B ZA 855124 B ZA855124 B ZA 855124B ZA 855124 A ZA855124 A ZA 855124A ZA 855124 A ZA855124 A ZA 855124A ZA 855124 B ZA855124 B ZA 855124B
- Authority
- ZA
- South Africa
- Prior art keywords
- drugs
- naphthyridines
- phenol
- preparing
- particularly anti
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyridine Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8411040A FR2567520B1 (fr) | 1984-07-11 | 1984-07-11 | Nouvelles phenyl-naphthyridines, leur procede de preparation, medicaments les contenant, notamment anti-ulceres |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA855124B true ZA855124B (en) | 1986-01-29 |
Family
ID=9306028
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA855124A ZA855124B (en) | 1984-07-11 | 1985-07-08 | Phenol-naphthyridines,process for preparing them,drugs containing them,particularly anti-ulcer drugs |
Country Status (15)
Country | Link |
---|---|
US (1) | US4622328A (de) |
EP (1) | EP0172058B1 (de) |
JP (1) | JPS6140287A (de) |
KR (1) | KR900004828B1 (de) |
AT (1) | ATE49209T1 (de) |
AU (1) | AU578295B2 (de) |
DE (1) | DE3575139D1 (de) |
DK (1) | DK306385A (de) |
ES (1) | ES8609319A1 (de) |
FR (1) | FR2567520B1 (de) |
GR (1) | GR851657B (de) |
NZ (1) | NZ212658A (de) |
PH (1) | PH21165A (de) |
PT (1) | PT80791B (de) |
ZA (1) | ZA855124B (de) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ218774A (en) * | 1986-01-06 | 1990-06-26 | Carpibem | 3-substituted phenylnaphthyridines and pharmaceutical compositions |
NZ218773A (en) * | 1986-01-06 | 1990-05-28 | Carpibem | 3-methyl-2-oxo-1-(substituted phenyl)-naphthyridines and pharmaceutical compositions |
US5037826A (en) * | 1986-10-15 | 1991-08-06 | Schering Corporation | 1-substituted naphthyridine and pyridopyrazine derivatives |
US4916131A (en) * | 1986-10-15 | 1990-04-10 | Schering Corporation | Naphthyridine derivatives and method for treating allergic reactions |
EP0267691A3 (de) * | 1986-10-15 | 1989-08-23 | Schering Corporation | Verwendung von 1-substituierten Naphthyridin- und Pyridopyrazinderivaten für die Herstellung von Immunosuppressoren-arzneimittel. |
US4775686A (en) * | 1986-10-15 | 1988-10-04 | Schering Corporation | Naphthyridine derivatives and method for treating allergic reactions |
US5760034A (en) * | 1990-11-30 | 1998-06-02 | Schering Corporation | Heterocyclic substituted naphthyridinones and methods and compositions employing them |
FR2706898B1 (de) * | 1993-06-25 | 1995-09-08 | Union Pharma Scient Appl | |
GB9622386D0 (en) * | 1996-10-28 | 1997-01-08 | Sandoz Ltd | Organic compounds |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4128649A (en) * | 1977-06-29 | 1978-12-05 | Sandoz, Inc. | 4-Hydroxy-pyrido[2,3-b]pyridine-2(1H)-one-3-carboxylic acids and esters |
US4133885A (en) * | 1977-07-18 | 1979-01-09 | Merck & Co., Inc. | Substituted naphthyridinones |
US4324893A (en) * | 1979-04-18 | 1982-04-13 | American Home Products Corporation | 4-Amino-3-carboxy or cyano-1,2-dihydro-2-oxo-1,8-naphthyridine derivatives |
US4215123A (en) * | 1979-05-07 | 1980-07-29 | American Home Products Corporation | Antisecretory 4-oxy-3-carboxy or cyano-1,2-dihydro-2-oxo-1,8-naphthyridine derivatives |
DE3368929D1 (de) * | 1982-04-26 | 1987-02-12 | Schering Corp | 1,8-naphthyridine and 1,5,8-azanaphthyridine derivatives |
-
1984
- 1984-07-11 FR FR8411040A patent/FR2567520B1/fr not_active Expired
-
1985
- 1985-07-02 US US06/751,610 patent/US4622328A/en not_active Expired - Fee Related
- 1985-07-03 DE DE8585401342T patent/DE3575139D1/de not_active Expired - Fee Related
- 1985-07-03 AT AT85401342T patent/ATE49209T1/de not_active IP Right Cessation
- 1985-07-03 EP EP85401342A patent/EP0172058B1/de not_active Expired - Lifetime
- 1985-07-04 GR GR851657A patent/GR851657B/el unknown
- 1985-07-04 DK DK306385A patent/DK306385A/da not_active Application Discontinuation
- 1985-07-05 NZ NZ212658A patent/NZ212658A/xx unknown
- 1985-07-08 ZA ZA855124A patent/ZA855124B/xx unknown
- 1985-07-09 ES ES545009A patent/ES8609319A1/es not_active Expired
- 1985-07-09 PT PT80791A patent/PT80791B/pt not_active IP Right Cessation
- 1985-07-09 AU AU44731/85A patent/AU578295B2/en not_active Ceased
- 1985-07-09 PH PH32496A patent/PH21165A/en unknown
- 1985-07-11 JP JP15144585A patent/JPS6140287A/ja active Granted
- 1985-07-11 KR KR1019850004946A patent/KR900004828B1/ko not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DK306385A (da) | 1986-01-12 |
PT80791A (fr) | 1985-08-01 |
ATE49209T1 (de) | 1990-01-15 |
JPS6140287A (ja) | 1986-02-26 |
ES545009A0 (es) | 1986-07-16 |
KR900004828B1 (ko) | 1990-07-07 |
PT80791B (pt) | 1987-09-18 |
AU578295B2 (en) | 1988-10-20 |
DE3575139D1 (de) | 1990-02-08 |
DK306385D0 (da) | 1985-07-04 |
AU4473185A (en) | 1986-01-16 |
US4622328A (en) | 1986-11-11 |
ES8609319A1 (es) | 1986-07-16 |
EP0172058B1 (de) | 1990-01-03 |
GR851657B (de) | 1985-11-26 |
FR2567520A1 (fr) | 1986-01-17 |
JPH0374668B2 (de) | 1991-11-27 |
PH21165A (en) | 1987-08-05 |
FR2567520B1 (fr) | 1987-01-02 |
NZ212658A (en) | 1988-02-29 |
KR860001108A (ko) | 1986-02-22 |
EP0172058A1 (de) | 1986-02-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CS725686A3 (en) | Process for preparing novel imidazole derivatives | |
IE832529L (en) | ß-CARBOLINES, PROCESS FOR THEIR PRODUCTION AND¹PHARMACEUTICAL PREPARATIONS CONTAINING THEM | |
DE3571982D1 (en) | Benzisoselenazolethiones,process for their preparation and pharmaceutical products containing these compounds | |
PT76495A (en) | Process for preparing new imidazolphenyl-tetrahydropyridazines | |
DE3667059D1 (en) | Benzodipyrroles, processes for their preparation and pharmaceutical compositions containing these compounds | |
HUT38340A (en) | Process for producing benzyl-phtalazinone derivatives and pharmaceutical compositions containing them | |
NZ216048A (en) | Quinolylglycinamide derivatives, and pharmaceutical compositions containing such | |
ZA855124B (en) | Phenol-naphthyridines,process for preparing them,drugs containing them,particularly anti-ulcer drugs | |
EP0144991A3 (en) | Polymethosybenzyl piperazine derivatives, processes for their preparation and pharmaceutical compositions containing said derivatives | |
ES8607263A1 (es) | Un procedimiento de preparacion de compuestos heterociclicos | |
ES8606374A1 (es) | Un procedimiento para preparar derivados de acido neuramini-co | |
IL75357A (en) | Primycin components,process for the separation of the antibiotic complex and antibiotic pharmaceutical compositions containing them | |
DE3463143D1 (en) | 1-0-alkyl-3-amino-propan-1.2-diol-2-0-phospholipids, process for producing the same and pharmaceutical preparations containing the same | |
AU3527484A (en) | N-benzyl-n-phenyl-b-pyrrolidinyl-f-isobutoxy-propylamine | |
ES8206544A1 (es) | Procedimiento para la preparacion de 4-carbamoiloxi-oxaza- fosforinas | |
ES8704487A1 (es) | Procedimiento para preparar derivados de 3,4-diazol | |
DE3275465D1 (en) | Thiolactime ethers of delta-1-pyrrolidine, and their preparation | |
ZA834739B (en) | Nonapeptide having immunostimulative activity,process for the preparation thereof and its use | |
IE812607L (en) | Heterobicyclic compounds | |
PL237124A2 (en) | Process for preparing novel compounds,derivatives of 3/1/-n-benzyloaminocarbamol |